I really can not see losing buying this under $5, it's really an investment as bio`s will still outperform in this market that have good trials.
Small bio`s have been beaten up of late as larger biotech/healthcare are getting the lion share of new purchases in hopes of buyouts, JMO.
Only current concern is gov. shutdown and how much this is going to affect the FDA`s backlog and how fast they can get back up to speed. Will not effect $TGTX for now.....